• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Suven Life Sciences Ltd Miscellaneous

  • Indian Private
  • BSE Code : 4916.0
  • ISIN : INE495B01038
266.80 -6 (-2.05%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    265.00

  • Today’s High

    278.00

  • Open

    275.60

  • Perv Close

    272.37

  • 52W Low

    102.50

  • 52W High

    299.99

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    5,818.21

  • Div & Yield %

    0.00

  • Book Value(₹)

    36.66

  • Debt-Equity Ratio

    -2.05

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    5,818.21

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    21.81

  • BV (₹)

    36.70

  • Sales( ₹ in Cr.)

    6.66

  • NP (in Cr.)

    -52.06

  • NP Var(%)

    -160.0

  • Div%

    0.0

  • CPS (₹)

    -2.10

  • EPS (₹)

    -2.40

  • Traded Value (₹ in Lakhs)

    5,808.39

  • 52 Week High

    299.99

  • 52 Week Low

    102.50

  • Price BSE

    266.0

  • Price NSE

    267.00

  • Market Capital( in Cr.)

    5,808.39

  • P/C Ratio

    -125.50

  • P/E Ratio

    -111.40

  • Price Vs.BV

    -2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 6.66 11.69 13.54 11.84 13.48 14.41
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6.66 11.69 13.54 11.84 13.48 14.41
Other Income 10.73 28.59 14.45 5.32 7.75 14.04
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 17.39 40.28 27.99 17.16 21.23 28.45
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.30 0.26 0.00 0.00 0.00 1.63
Employee Cost 20.82 16.53 15.77 17.46 15.29 14.60
Other Manufacturing Expenses 1.79 1.54 0.93 2.59 0.14 0.02
Selling and Administration Expenses 34.27 23.06 22.95 27.01 27.61 30.26
Miscellaneous Expenses 1.31 1.15 1.52 1.30 0.89 3.17
Employee Benefit Expenses 20.82 16.53 15.77 17.46 15.29 14.60
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 58.49 42.55 41.18 48.37 43.93 49.68
Operating Profit -41.11 -2.27 -13.18 -31.22 -22.70 -21.23
Interest 0.15 0.24 0.40 0.64 0.91 0.54
Gross Profit -41.26 -2.51 -13.58 -31.86 -23.61 -21.77
Depreciation 5.82 6.50 6.54 4.39 4.35 4.17
Profit Before Tax -47.08 -9.01 -20.12 -36.25 -27.96 -25.94
Current Tax 0.00 -1.00 0.00 0.00 0.38 2.28
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 -5.70 -14.46
Reported Net Profit -47.08 -8.01 -20.13 -36.25 -22.63 -13.75
Extraordinary Items 4.98 12.01 7.79 3.99 0.06 0.50
Adjusted Net Profit -52.06 -20.02 -27.92 -40.24 -22.69 -14.25
Adjustment below Net Profit -0.06 -0.06 0.19 -0.15 -0.31 -0.30
P & L Balance brought forward 133.43 141.49 161.43 197.83 220.77 234.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 86.29 133.43 141.49 161.43 197.83 220.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.16 -0.37 -0.92 -2.49 -1.78 -1.08
Earnings Per Share(Adj)-Unit Curr -2.16 -0.37 -0.92 -2.29 -1.64 -1.00
Book Value 36.66 38.77 39.14 32.74 28.66 30.46
Book Value(Adj)-Unit Curr 36.66 38.77 39.14 30.17 26.41 28.07

Shareholding Pattern

  • Promoter Group

    67.43%

  • Public Share Holding

    32.57%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 151,697,500 66.75 151,697,500 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,533,736 0.67 1,533,736 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 153,231,236 67.43 153,231,236 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,273,332 0.56 1,273,332 16
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 4,721,940 2.08 4,703,940 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,021,037 1.33 3,021,037 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,016,409 3.97 8,998,409 26
2] Non Institution
Bodies Corporate 5,969,111 2.63 5,967,111 373
Clearing Members 26 0.00 26 1
Directors of their Relatives 325,637 0.14 325,637 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,159,360 1.83 4,159,360 1,302
Foreign Non Institution Other 1,500,000 0.66 1,500,000 1
Hindu Undivided Families 2,204,279 0.97 2,204,279 1,232
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,454,049 1.96 4,454,049 18
Individuals holding nominal share capital up to Rs. 1 lakh 46,088,267 20.28 45,915,759 62,611
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 309,760 0.14 309,760 1
Sub Total 65,012,562 28.61 64,838,054 65,542
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 227,260,207 100.00 227,067,699 65,574

Company Background

Suven Life Sciences LtdMiscellaneous

  • Suven Life Sciences Ltd
  • BSE Code : 4916.0
  • ISIN : INE495B01038

  • Incorporation Year

    1989

  • Registered Office

    #8-2-334 SDE Serene Chambers
    6 th Floor Road No 5 Avenue 7, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23541142/3311/3315

  • FAX

    91-40-23541152

  • Chairman

    Venkateswarlu Jasti

  • Managing Director

  • Company Secretary

    Shrenik Soni

  • Auditor

    Karvy & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Suven Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Suven Life Scie. 266.35 17.38 6.66 -123.31 -6.30
Apollo Hospitals 7,344.10 7,453.70 7,273.80 81.46 15.48
Kovai Medical 6,260.65 1,393.22 1,371.11 32.78 22.84
Vimta Labs 688.45 348.22 343.98 41.80 24.14
One Global Serv 258.15 63.01 63.01 27.32 77.53
Shree Pacetronix 75.65 22.17 22.04 36.20 34.41
Fortis Malar 69.94 2.72 0.00 317.91 0.86
Medinova Diagno. 41.54 8.04 7.78 38.46 9.69
Chennai Meena 33.00 38.68 38.20 -17.93 0.00
Genesis IBRC 29.82 0.00 0.00 11.04 0.00
Transgene Biotek 4.60 0.42 0.23 -51.11 0.00